longbridge

Nuvectis Pharma

NVCT
----

All Shareholders

Shareholder Type

  • Individuals & Insiders34.92%
  • Institutions33.79%
  • Public and others31.29%

Major Shareholders

Major Shareholders Latest
Shareholder
Ron BentsurCo-Founder, Chairman, CEO & President
11.32%3.69M2.54%+12.50K
Charles Mosseri-Marlio
10.12%3.30M2.12%+50.00K
Enrique PoradosuCo-Founder, Executive VP, Chief Scientific & Business Officer
5.54%1.81M1.27%+0
Shay ShemeshCo-Founder, Executive VP, Chief Development & Operations Officer
5.50%1.79M1.26%+0
Tang Capital Management, LLC
4.76%1.55M--+1.55M
Soleus Capital Management, L.P.
4.60%1.50M0.85%+498.02K
BlackRock, Inc.
3.07%1.00M0.19%+236.84K
Vanguard Capital Management, LLC
3.07%1.00M0.15%+225.32K
Perceptive Advisors LLC
3.07%1.00M--+1.00M
Iridian Asset Management LLC
2.43%793.21K0.48%+16.13K
Geode Capital Management, LLC
1.33%432.27K0.12%+48.17K
Sphera Funds Management Ltd
1.18%382.95K--+382.95K
Baldwin Wealth Partners, LLC
1.17%382.02K0.26%+0
Occam Crest Management LP
1.10%357.15K0.44%-50.00K
Alyeska Investment Group, L.P.
0.84%275.00K--+275.00K
State Street Investment Management
0.76%248.20K0.13%+81.68K
Michael CarsonVice President of Finance
0.71%230.12K0.04%+30.00K
Susquehanna International Group, LLP
0.67%217.29K0.27%+112.00K
Avidity Partners Management, L.P.
0.61%200.00K--+200.00K
Kenneth HobermanIndependent Director
0.52%168.14K0.01%+35.00K
© 2026 Longbridge｜Terms of ServicePrivacy Policy